Lactobacillus crispatus
A vaginal bacterium linked to a healthy, acidic vaginal environment; oral and vaginal products are still being tested.
- Also called
- L. crispatus
- In our formulas
- 2
- Studies cited
- 3
What it is
Lactobacillus crispatus is a lactic-acid bacterium that dominates the vaginal flora in many healthy women. It makes lactic acid, which keeps the vagina acidic.
Most research uses specific strains, such as M247 taken by mouth, or CTV-05 given vaginally.
What the research says
-
Early research
Supports a healthy balance of vaginal flora.*
In a 2026 randomized study, postmenopausal women with vaginal dryness and discomfort had laser therapy alone or laser plus oral L. crispatus M247 for 90 days. The probiotic group ended with lower scores in some symptom areas and more L. crispatus in their vaginal flora, though pH changed alike in both groups. In a trial of 45 women aged 18 to 23, a vaginal L. crispatus product made it the main vaginal bacterium in 41% at week 4, against none on placebo, but the effect faded by week 8. A 2025 review of 16 trials found L. crispatus promising at 100 million to 5.4 billion CFU a day1,2,3.
What to look for on a label
Look for the full strain name (for example M247 or CTV-05), the CFU count at expiration, and a delivery method that survives stomach acid.
Evidence does not carry over from one strain to another.
How First Organic uses it
Fembiotic+ and Intimatease+ both contain it. Each uses Lactobacillus crispatus as one of five strains in a 10 billion CFU Vaginal Probiotic Blend, taken by mouth. The label gives one count for the whole blend and does not name the crispatus strain. Because results in this field belong to specific strains, the trials above show what the species can do, not what our capsule has been tested to do.
| Formula | Per serving |
|---|---|
| Fembiotic+ | in the vaginal probiotic blend (5 strains), 10 billion cfu |
| Intimatease+ | in the vaginal probiotic blend (5 strains), 10 billion cfu |
Amounts are from each product's supplement facts panel. "In the blend" means the label gives one total for a group of ingredients.
Before you take it
Ask a doctor first if you are immunocompromised, have a central line or are seriously ill. Mild gas or bloating can occur.
References
-
1
Di Pierro F, Filippini M, Lucia M, et al. Clinical and vaginal microbiota effects of oral Lactobacillus crispatus M247 combined with vaginal laser therapy in menopausal women with atrophic vulvovaginitis: a prospective, randomized and controlled study Lasers Med Sci, 2026. randomised trial
-
2
Hemmerling A, Mitchell CM, Demby S, et al. Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial Lancet Microbe, 2025. randomised trial
-
3
Udjianto U, Sirat NA, Rahardjo B, et al. Effective probiotic regimens for bacterial vaginosis treatment and recurrence prevention: A systematic review Narra J, 2025. review
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. This guide is general information, not medical advice.